
The outpatient prescription drug market, which was slow in winter, is showing a recovery trend.
Since the end of last year, the total prescription drug volume has been on a decline compared to the previous year, but in March it turned to an upward trend.
It is analyzed that COVID-19 showed sluggishness due to a sharp decline in infectious disease patients due to the prolonged aftermath of the prolonged aftermath, but rebounded at the end of the flu season.
According to the drug research institute UBIST on the 18th, the total outpatient prescription amount in the first quarter of the year was ₩3.5697 trillion, down 3.6% from the same period last year.
Compared to the first quarter of 2019, it also decreased by 0.9%.
The prescription size has increased every year, but this year has decreased.
The prescription size in the first quarter of last year was ₩3.701 trillion, an increase of 2.7% from the previous year.
In the first quarter of 2018 and 2019, prescriptions rose 8.9% and 5.5%, respectively, compared to the previous year.
This is the aftermath of the sluggish prescriptions in January and February.
The prescription size in January was ₩1,166.6 billion, down 7.0% from the previous year, and 5.6% in February compared to the same period last year.

Since December of last year, the total prescription drug volume has declined compared to the previous year for three consecutive months, and then turned to an upward trend in April.
The sluggish prescription market in January and February was largely attributed to the prolonged COVID-19.
Since the spread of COVID-19, it is highly likely that the incidence of infectious diseases has greatly decreased due to reinforced personal hygiene management such as hand washing and wearing a mask, leading to a decrease in visits to medical institutions.
Since the end of last year, no flu pandemic warning has been issued this winter.
According to the KCDA, the number of suspected flu patients per 1,000 outpatients during the 1st to 8th week of this year is 2.4, 2.4, 2.6, 2.3, 1.9, 1,9, 1.9, 2.0, etc.
Compared to 49.1, 47.8, 42.4, 40.9, 28.0, 16.4, 11.6, and 8.5 outpatients per 1,000 outpatients during the 1st to 8th week of last year, there have been few recent flu cases.
Since the end of last year, it is possible that visits to medical institutions have further decreased as the social distancing stage has been elevated due to the rapid increase in the number of COVID-19 confirmed patients.
As more than 300 confirmed cases occurred from November 18 last year, the government raised the social distancing from November 24 to the second stage from the previous 1.5 stage.
From then on, only packaging and delivery were allowed for cafes regardless of business hours, and only packaging and delivery were allowed after 9 pm for restaurants.
Nevertheless, as the number of COVID-19 confirmed rapidly increased, the government raised the social distance in the metropolitan area to 2.5 steps from December 8 last year.
Accordingly, in the metropolitan area, the operation of singing practice centers and indoor sports facilities in addition to the existing five types of entertainment facilities such as entertainment bars was additionally suspended.
Shops, marts, department stores, movie theaters, PC cafes, and other facilities that are closely related to life must also close after 9 pm.
Despite the rise in social distancing, the number of COVID-19 confirmed exceeding 1,000 and hitting a daily high, the Seoul Metropolitan Government implemented a super-precipitation measure that banned ``private gatherings with more than 5 people'' from December 23 last year, and such measures have been taken across the country since.
Was applied to spread.
Since last February, the social distancing step in the metropolitan area has been eased to two stages, but strengthened distancing measures are being implemented, such as “private gatherings for more than 5 people” are still banned.
However, as the flu season ended in March, it is analyzed that the growth rate of the previous year has recovered.
The number of suspected flu patients per 1,000 outpatients during the 9th to 13th week of this year was 1-2, similar to that of January and February.
There is no significant difference from the 9th to 13th week of last year.
Last year, it recorded 6.3 in the 9th week, but as the flu season ended, it decreased to 3.9 in the 10th week, 2.9 in the 11th week, 3.2 in the 12th week, and 2.8 in the 13th week.
The industry diagnoses that the prolonged COVID-19 will inevitably hurt the prescription market for drugs used by flu or cold patients.
However, as the use of medicines continues to increase due to the increase in the elderly population and the number of chronic diseases, the overall prescription market is expected to show an increase at the level of previous years.
Although social distancing is still in place, it is observed that unlike the tourism and cultural industries that fell into extreme crises after COVID-19 outbreak, the pharmaceutical industry is affected by the demands of patients rather than the external environment, so it is difficult to lead to a sudden downturn.
댓글 운영방식은
댓글은 실명게재와 익명게재 방식이 있으며, 실명은 이름과 아이디가 노출됩니다. 익명은 필명으로 등록 가능하며, 대댓글은 익명으로 등록 가능합니다.
댓글 노출방식은
댓글 명예자문위원(팜-코니언-필기모양 아이콘)으로 위촉된 데일리팜 회원의 댓글은 ‘게시판형 보기’와 ’펼쳐보기형’ 리스트에서 항상 최상단에 노출됩니다. 새로운 댓글을 올리는 일반회원은 ‘게시판형’과 ‘펼쳐보기형’ 모두 팜코니언 회원이 쓴 댓글의 하단에 실시간 노출됩니다.
댓글의 삭제 기준은
다음의 경우 사전 통보없이 삭제하고 아이디 이용정지 또는 영구 가입제한이 될 수도 있습니다.
저작권·인격권 등 타인의 권리를 침해하는 경우
상용 프로그램의 등록과 게재, 배포를 안내하는 게시물
타인 또는 제3자의 저작권 및 기타 권리를 침해한 내용을 담은 게시물
근거 없는 비방·명예를 훼손하는 게시물
특정 이용자 및 개인에 대한 인신 공격적인 내용의 글 및 직접적인 욕설이 사용된 경우
특정 지역 및 종교간의 감정대립을 조장하는 내용
사실 확인이 안된 소문을 유포 시키는 경우
욕설과 비어, 속어를 담은 내용
정당법 및 공직선거법, 관계 법령에 저촉되는 경우(선관위 요청 시 즉시 삭제)
특정 지역이나 단체를 비하하는 경우
특정인의 명예를 훼손하여 해당인이 삭제를 요청하는 경우
특정인의 개인정보(주민등록번호, 전화, 상세주소 등)를 무단으로 게시하는 경우
타인의 ID 혹은 닉네임을 도용하는 경우
게시판 특성상 제한되는 내용
서비스 주제와 맞지 않는 내용의 글을 게재한 경우
동일 내용의 연속 게재 및 여러 기사에 중복 게재한 경우
부분적으로 변경하여 반복 게재하는 경우도 포함
제목과 관련 없는 내용의 게시물, 제목과 본문이 무관한 경우
돈벌기 및 직·간접 상업적 목적의 내용이 포함된 게시물
게시물 읽기 유도 등을 위해 내용과 무관한 제목을 사용한 경우
수사기관 등의 공식적인 요청이 있는 경우
기타사항
각 서비스의 필요성에 따라 미리 공지한 경우
기타 법률에 저촉되는 정보 게재를 목적으로 할 경우
기타 원만한 운영을 위해 운영자가 필요하다고 판단되는 내용
사실 관계 확인 후 삭제
저작권자로부터 허락받지 않은 내용을 무단 게재, 복제, 배포하는 경우
타인의 초상권을 침해하거나 개인정보를 유출하는 경우
당사에 제공한 이용자의 정보가 허위인 경우 (타인의 ID, 비밀번호 도용 등)
※이상의 내용중 일부 사항에 적용될 경우 이용약관 및 관련 법률에 의해 제재를 받으실 수도 있으며, 민·형사상 처벌을 받을 수도 있습니다.
※위에 명시되지 않은 내용이더라도 불법적인 내용으로 판단되거나 데일리팜 서비스에 바람직하지 않다고 판단되는 경우는 선 조치 이후 본 관리 기준을 수정 공시하겠습니다.
※기타 문의 사항은 데일리팜 운영자에게 연락주십시오. 메일 주소는 dailypharm@dailypharm.com입니다.